I think Motley Fool finally decided to say something positive...

I think Motley Fool finally decided to say something positive about Blast (no option left tbh):

"Is the Aussie biotech in the buy zone?Clearly, speculators who rolled the dice after the heavy share price falls have done well.However, if you’re a long-term investor like myself, you should really be buying and holding for decades to come.I personally like Mesoblast shares and their future prospects. The company has some promising treatments in Phase 3 trials including Ryoncil for aGVHD.I think Friday’s share price rally just puts Mesoblast shares back to their initial intrinsic value.If you’re a big believer in the biotech industry, I think Mesoblast is a good option. The key with biotech companies is a strong research and development pipeline coupled with positive momentum.Mesoblast appears to have both of these factors which makes the future outlook strong. Of course, there will be more speed bumps along the way.If you’re looking for less growth and a more mature company profile, I think CSL Limited (ASX: CSL) shares could be another strong biotech buy."